Industry Events
Our organization hosts events throughout the year covering topics on diversity, patients, careers & leadership, regulatory affairs, government relations, and business growth.
On this edition of Founder’s Story, Rev 1 Ventures will host a breakfast with DASI Simulations’s team who performs advanced individualized computational predictive modeling powered by artificial intelligence and computer vision to better plan for improved patient outcomes and reduced costs associated with Structural Heart Disease.
A dramatic shift in regulatory opinions has occurred within the last several years regarding the concepts of Extractables and Leachables (E&L) testing of medical devices, commonly known as Chemical Characterization. Much of that change was driven by the 2020 revision to ISO 10993-18. Join NAMSA for this webinar to learn more about the foundations behind Chemical Characterization and to examine best practices deriving from it.
